A leading coronavirus-vaccine candidate being developed by University of Oxford researchers and pharmaceutical company AstraZeneca showed positive results in early trials, raising the prospect that a shot could be available by the end of this year
LONDON—A leading coronavirus-vaccine candidate being developed by University of Oxford researchers and AstraZeneca PLC showed positive results in early trials, according to results published Monday, raising the prospect that a shot could be available by the end of this year.
A study of 1,077 healthy adults who received the vaccine showed it produced two kinds of immune response that could defend a body against Covid-19, according to results published in the Lancet, a British medical journal. The vaccine caused no serious side...
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Coronavirus vaccine from Oxford and AstraZeneca shows positive response in early trialA potential coronavirus vaccine developed by Oxford University in the U.K. has produced an immune response in an early-stage human trial, according to newly released data published Monday in medical journal The Lancet.
Read more »
Oxford coronavirus vaccine generates promising Phase 1/2 results: Study
Read more »
First human trial of AstraZeneca COVID-19 vaccine shows promiseAstraZeneca&39;s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday. The vaccine, called AZD1222 and being developed by AstraZeneca and scientists at Britain&39;s University of Oxford, did not prompt any
Read more »
Britain signs deals with Pfizer, BioNTech, Valneva for COVID-19 vaccinesBritain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from the Pfizer Inc and BioNTech alliance and French group Valneva, the business ministry said on Monday.
Read more »
British pharma firm claims small trial on a coronavirus treatment could signal 'major breakthrough'British pharmaceutical company Synairgen has claimed that its new respiratory coronavirus treatment has reduced the number of hospitalized Covid-19 patients needing intensive care in a clinical trial.
Read more »
It's No Surprise Black Communities Are Disproportionately Suffering During the COVID-19 Pandemic'This coronavirus preys on people with underlying health conditions, many of which Black people suffer from at disproportionate rates.' SenKamalaHarris writes:
Read more »